冠状动脉无复流的研究进展
摘要
急诊经皮冠状动脉介入治疗(PCI)是治疗急性心肌梗死(AMI)的重要方法,但有部分患者梗死血管开通后心肌灌注不良,此种现象即为无复流。无复流可能的发生机制包括:血管内皮损伤、微栓塞、白细胞聚集、氧自由基的激活、血小板及凝血级联反应的激活等。研究提示,一些临床因素和生化指标的异常与无复流的发生密切相关,而应用血管扩张剂、抗血小板药物、血栓抽吸装置、远端保护装置、缺血预适应等可预防无复流。无复流的发生提示预后不良,进而越来越引起人们的重视。现就无复流的研究进展综述如下。
出处
《中国实用医刊》
2012年第10期97-99,共3页
Chinese Journal of Practical Medicine
参考文献18
-
1Galuto L. Optimal therapeutic strategies in the setting of post-infarction no reflow:the need for a pathogenetic classification[J].Heart,2004,(02):123-125.doi:10.1136/hrt.2003.020800.
-
2Topoi EJ,Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease[J].Circulation,2000,(05):570-580.
-
3Kleinbongard P,Bose D,Baars T. Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation[J].Circulation Research,2011,(03):344-352.doi:10.1161/CIRCRESAHA.110.235713.
-
4Golino P,Ragni M,Cirillo P. Recombinant human active siteblocked factor Ⅶ reduces infract size and no-reflow phenomenon in rabbits[J].Am J Physinl,2000,(05):1507-1516.
-
5Kupatt C,Wichels R,Horstkotte J. Molecular mechanisms of platelet mediated leukocyte recruitment during myocardial reperfusion[J].Journal of Leukocyte Biology,2002,(03):455-461.doi:10.1142/S0218196711006856.
-
6Yip HK,Chen MC,Chang HW. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction:predictors of slow-flow and no-reflow phenomenon[J].Chest,2002,(04):1322-1332.
-
7Oduncu V,Tanalp AC,Erkol A. Impact of chronic pre-treatment of statins on the level of systemic inflammation and myocardial peffusion in patients undergoing primary angioplasty[J].Journal of the American College of Cardiology,2011,(02):179-185.
-
8Takahashi T,Hissa Y,Dhara Y. Relation between neutrophil counts on admission,microvascular injury,and left ventricular functional recovery in patients with an anterior wall first acute myocardial infaction treated with primary coronary angioplasty[J].American Journal of Cardiology,2007,(01):35-40.doi:10.1016/j.amjcard.2007.02.049.
-
9Niccoli G,Lanza GA,Shaw S. Endothelin-1 and acute myocardial infarction:a no-reflow mediator after successful percutaneous myocardial revascularization[J].European Heart Journal,2006,(05):1793-1798.
-
10Henriques JP,Zijlstra F,Arnoud WJ. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade[J].Circulation,2003,(16):2115-2119.doi:10.1161/01.CIR.0000065221.06430.ED.
二级参考文献8
-
1赵京林,杨跃进,尤士杰,荆志成,吴永建,杨伟宪,陈纪林,高润林,陈在嘉.腺苷对猪急性心肌梗死再灌注后内皮素-1的影响[J].中国医学科学院学报,2006,28(2):225-229. 被引量:8
-
2Pernow J, Wang Q D. Endothelin in ischaemia and reperfusion [J]. Cardiovasc Res, 1997, 33 (3) : 518-526.
-
3Niccoli G, Lanza G A, Shaw S, et al. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization [ J ]. Eur Heart J, 2006, 27 ( 15 ) : 1793-1798.
-
4Katsuomi Iwakura, Ito H, Kawano S, et al. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction [J]. Eur Heart J, 2006 , 27(5) :534-539.
-
5Herrmann J. Peri-procedural myocardial injury: 2005 update [J]. Eur Heart J, 2005, 26(23) : 2493-2519.
-
6Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction [J]. Nat Clin Pract Cardiovasc Med, 2006, 3 (9) : 499-506
-
7Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial [J]. J Am Coll Cardiol, 2007, 49(12):1272-1278.
-
8Lefer D J. Statins as potent antiinflammatory drugs [J]. Circulation, 2002, 106(16) : 2041-2042.
共引文献6
-
1沈青青,肖文良.冠状动脉介入术无复流现象的药物治疗进展[J].心脏杂志,2011,23(3):403-405. 被引量:10
-
2雷晓明,李韶南,黄慧芳,刘震,陈平安.直接PCI术前使用负荷剂量他汀对急性心肌梗死患者的心肌保护作用[J].实用医学杂志,2011,27(23):4290-4292. 被引量:7
-
3张薇.冠状动脉介入治疗前强化他汀治疗的获益——从指南到临床[J].中国循证心血管医学杂志,2013,5(4):327-328. 被引量:11
-
4宋琼,毕丽丽,张金杰,任瑞,赵希军.阿托伐他汀对冠状动脉无复流作用机制的研究进展[J].医药导报,2021,40(5):641-644. 被引量:3
-
5慈东岳,庞茜,王震,王咏.冠脉无复流现象的相关因子和中医药治疗进展[J].海南医学院学报,2023,29(6):475-480. 被引量:1
-
6林蓉香,张亚萍.冠脉介入术中无复流现象药物治疗的研究进展[J].健康之路,2016,0(11):23-23.
-
1陆浩,葛均波.AngioJet机械血栓抽吸装置在急性ST段抬高型心肌梗死直接经皮冠状动脉介入治疗中的应用[J].上海医学,2013,36(9):746-748. 被引量:6
-
2张小兵,杨帆,夏思良.血栓抽吸联合替罗非班在急性心肌梗死患者预后中的疗效评价[J].实用临床医药杂志,2017,21(5):110-112. 被引量:13
-
3冯旭光,娜荣.疏血通注射液对冠状动脉介入术中慢血流和无复流的影响[J].中西医结合心脑血管病杂志,2013,11(12):1438-1439. 被引量:6
-
4王超群,石兵,陈俊贤.硝普钠联合替罗非班治疗急性心肌梗死急诊PCI冠状动脉无复流的效果观察[J].临床医学工程,2017,24(4):501-502. 被引量:5
-
5杨永健.冠状动脉“无复流”的防治进展[J].中华保健医学杂志,2009,11(2):152-153. 被引量:7
-
6赵兴全,杜文涛,袁江永,智华,李亚.抽吸导管联合替罗非班对急性ST段抬高型心肌梗死患者冠状动脉无复流的影响[J].中国综合临床,2014,30(2):125-127. 被引量:7
-
7郭艳霞,陆士奇,何磊磊,李静,肖接承.急性心肌梗死患者γ-GGT水平与冠状动脉无复流的相关性分析[J].浙江临床医学,2015,17(9):1494-1496. 被引量:3
-
8常快乐,王海昌,陶凌,贾敏,廉坤,刘毅,杨璐,马新亮.强化他汀治疗对经皮冠状动脉介入术患者冠状动脉无复流及血浆相关因子的影响[J].临床内科杂志,2012,29(9):606-609. 被引量:7
-
9许春平,赵献明,黄惠慧.血栓抽吸联合冠状动脉内注射替罗非班对急性心肌梗死预后影响[J].现代诊断与治疗,2013,24(8):1785-1786. 被引量:1
-
10郭静萱,刘健.抗栓治疗出血与缺血的平衡[J].中国循环杂志,2011,26(1):1-3. 被引量:8